Filing Details

Accession Number:
0000950170-23-005192
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-28 17:01:26
Reporting Period:
2023-02-27
Accepted Time:
2023-02-28 17:01:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1756262 Transmedics Group Inc. TMDX Electromedical & Electrotherapeutic Apparatus (3845) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1773661 M Edward Basile C/O Transmedics Group, Inc.
200 Minuteman Road
Andover MA 01810
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-02-27 1,500 $76.20 21,314 No 4 S Direct
Common Stock Disposition 2023-02-27 1,500 $78.17 19,814 No 4 S Direct
Common Stock Disposition 2023-02-27 2,000 $79.38 17,814 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $76.00 to $76.54, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $78.00 to $78.50, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $79.25 to $79.50, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.